Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Division of Gastroenterology & Hepatology, Loma Linda University Health, Loma Linda, CA, USA .
Clin Transl Gastroenterol. 2024 Jul 1;15(7):e00715. doi: 10.14309/ctg.0000000000000715.
INTRODUCTION: Long-term studies characterizing the natural history of functional bowel disorder (FBD) from community-based settings and exploring association with psychological factors are sparse. We aimed to evaluate the evolution of symptoms, health outcomes, and association of FBD with psychological disorders in Chinese population. METHODS: Individuals identified from random sampling of residents of Hangzhou, China, participated in a baseline survey in January 2010. Follow-up phone survey was conducted in December 2018. FBD was diagnosed based on Rome III criteria. RESULTS: Among 452 individuals (mean age 44.6 ± 15.3 years, 174 [38%] male) who completed the study, the prevalence of FBD was 36.3% (95% confidence interval [CI] 32.6-40.0%) at enrollment and 36.1% (95% CI 32.3-39.8%) at follow-up survey ( P = 0.94). However, 214 individuals (47%) had interval change in diagnosis. Although no difference in incidence of organic disease or death was observed, a higher proportion of patients with FBD (16/164, 9.8% vs 9/288, 3.1%; P = 0.003) compared with those without FBD received non-cancer-related abdominal and/or pelvic surgery during follow-up. FBD was associated with anxiety and/or depression at initial (adjusted odds ratio [AOR] = 1.7, 95% CI 1.7-2.7, P = 0.02) and follow-up (AOR = 8.0, 95% CI 3.2-20.0, P < 0.001) surveys. Diagnosis of FBD at baseline was associated with new-onset anxiety and/or depression at follow-up (AOR = 3.2, 95% CI 1.2-8.3, P = 0.01). DISCUSSION: Although the prevalence of FBD remained stable, transformation of symptoms was common over time. Patients with FBD may have increased risk of receiving non-cancer-related abdominal and/or pelvic surgery. FBD symptoms at baseline increased the risk of new-onset anxiety and/or depression by 3.2-fold over the next 9 years.
简介:从社区环境中描述功能性肠病(FBD)自然史并探索其与心理因素关联的长期研究较为匮乏。我们旨在评估中国人群中 FBD 症状、健康结局的演变以及与心理障碍的关联。
方法:从中国杭州的居民中随机抽样,识别出参与者,并于 2010 年 1 月进行基线调查。2018 年 12 月进行随访电话调查。基于 Rome III 标准诊断 FBD。
结果:在完成研究的 452 名个体(平均年龄 44.6±15.3 岁,174 名男性[38%])中,FBD 的患病率在入组时为 36.3%(95%置信区间[CI] 32.6-40.0%),随访时为 36.1%(95%CI 32.3-39.8%)(P=0.94)。然而,214 名个体(47%)的诊断有间隔变化。尽管未观察到器质性疾病或死亡的发生率差异,但与无 FBD 的个体相比,更多 FBD 患者(16/164,9.8%比 9/288,3.1%;P=0.003)在随访期间接受了非癌症相关的腹部和/或盆腔手术。FBD 在初诊(调整后优势比[AOR] = 1.7,95%CI 1.7-2.7,P=0.02)和随访(AOR = 8.0,95%CI 3.2-20.0,P<0.001)时与焦虑和/或抑郁相关。基线 FBD 诊断与随访时新发焦虑和/或抑郁相关(AOR = 3.2,95%CI 1.2-8.3,P=0.01)。
讨论:尽管 FBD 的患病率保持稳定,但症状随时间的转变较为常见。FBD 患者可能有更高的接受非癌症相关腹部和/或盆腔手术的风险。FBD 症状基线增加了未来 9 年内新发焦虑和/或抑郁的风险 3.2 倍。
Clin Transl Gastroenterol. 2024-7-1
World J Gastroenterol. 2013-3-7
Int J Colorectal Dis. 2006-12
World J Gastroenterol. 2012-6-21
Am J Gastroenterol. 2004-1
J Neurogastroenterol Motil. 2023-4-30
Clin Gastroenterol Hepatol. 2022-8
Lancet Gastroenterol Hepatol. 2021-8
Lancet Gastroenterol Hepatol. 2020-7-20